RecruitingNCT05703685
PET imaging of PDE4B during major depressive episodes
About this title
Read the official source — NCT05703685Medication studyAges 18–70United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
What will I do during this study?
The protocol includes: Having magnetic resonance imaging (MRI) scans.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 22, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 108
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Medication / drug, RADIATION
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT05703685
- Official title
Show the full official title
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
Recruitment & locations
RecruitingBethesda
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Does this study involve medication?
Yes. The study involves medication, including Apremilast and 18F-PF-06445974.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
